National dental epidemiology programme: Oral health survey of 3-year-old children 2019 to 2020: national protocol – Public Health England

Describes the methods fieldworkers should use to collect oral health information for the survey of 3 year olds in the academic year 2019 to 2020.  The population group for study is 3 year old children attending nurseries and playgroups. The

Government Response to the Health and Social Care Select Committee report on Drugs Policy: Medicinal Cannabis – HM Government

The government’s response to the Health and Social Care Committee’s report.  It details the government’s response to all 11 recommendations from the Drugs policy: medicinal cannabis: Sixteenth Report of Session 2017–19: Report, together with formal minutes relating to the report

The macroeconomic impact of government innovation policies: A quantitative assessment – University College London Institute for Innovation and Public Purpose

This report was funded by Innovate UK, part of UK Research and Innovation, for a research project undertaken by the IIPP and UCL Institute for Sustainable Resources. It introduces a new theoretical framework for understanding the links between fiscal policy

The people’s prescription: Re-imagining health innovation to deliver public value – University College London Institute for Innovation and Public Purpose

This is a policy report on re-imagining health innovation to deliver public value.  A thriving health innovation system is characterised by its ability to generate new health technologies that improve public health and ensure access to effective treatments for the

Health innovation re-imagined to deliver public value – University College London Institute for Innovation and Public Purpose

A thriving health innovation system is characterised by its ability to generate new health technologies that improve public health and ensure access to effective treatments for the people who need them (World Health Organization, 2018). However, the existing health innovation

Chief Medical Officer annual report 2019: Partnering for progress – Department of Health and Social Care

Latest Chief Medical Officer’s report considers current and future UK engagement with global health.  The report consists of 21 letters from global health leaders to the Chief Medical Officer and their rsponse, responding summary, recommendations and epilogue. The report publishes

Health in all Local Industrial Strategies? – NHS Confederation

The government published its Industrial Strategy in November 2017, setting out a long-term plan to create an economy that boosts productivity and earning power throughout the UK. Critically, every local economic area in England, along with the devolved administrations, is

A new ambition for crosssector collaboration with the life sciences industry to support NHS sustainability and transformation – NHS Confederation

The NHS must be an active participant with industry in delivering the shared objective of outstanding patient outcomes. In part that is because it is a monopoly purchaser but also because the NHS should be where innovative products are developed

National Survey Of Local Innovation And Research Needs Of The NHS: Full Report – The AHSN Network

This report includes analysis of the innovation and research needs at local level across all Academic Health Science Networks. There were some differences in regional priorities but common themes emerged which reflected wider challenges facing the NHS and align with

Involving Patients and Carers in Quality Improvement Projects: A Practical Guide – Central and North West London NHS Foundation Trust

This guide explains how to involve patients and carers in Quality Improvement (QI) projects. The toolkit covers topics such as: How to pay service users and carers How to recruit service users and carers How to run effective and inclusive meetings

Organising for excellence: An international review of good practice in organisational design and governance of research funding bodies – RAND Europe

This study presents a review of international evidence on best practice in organisational design of research and innovation funding bodies.

Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation – Office for Health Economics

This report summarise research evaluating the main legal barriers to the better use of health data for pharmaceutical innovation. Issues are evaluated according to barriers arising in utilising data to support key activities across the lifecycle of a medicine: epidemiology

From Patent to Patient: Analysing access to innovative cancer drugs – Institute of Cancer Research

Report that looks at how to best harness advances in science to bring innovative drugs to patients. It is designed to help us reshape the landscape for drug discovery and development – and create tomorrow’s cancer treatments.

Innovation in AMR: patent trends for novel diagnostics – Nesta

Research into patents and connected patent families using keywords relevant to point-of-care (POC) diagnostic tests for addressing antimicrobial resistance. This research analysed what patents are being filed and therefore what technology is being developed. The report assesses the implications on

Seven principles for public engagement in research and innovation policymaking: A guide from Nesta’s Inclusive Innovation team – Nesta

Why should researchers, innovators and those whose jobs it is to regulate technology engage with people who aren’t like them on topics like research and innovation? To give those in power a broader range of potential futures to aspire to

Ensuring access to medicines: How to stimulate innovation to meet patients’ needs?: (Policy Brief 29) – European Observatory on Health Systems and Policies

Brief that aims to inform discussions about stimulating more meaningful productivity in terms of pharmaceutical R&D. More specifically, it explores how R&D efforts can be steered to areas of unmet clinical needs and how efficiency in the R&D process can

Research integrity: clinical trials transparency: Tenth Report of Session 2017–19 Report, together with formal minutes relating to the report – House of Commons Science and Technology Committee

Selective non-publication of the results of research distorts the published evidence base and is a threat to research integrity. In the case of clinical trials, non-publication of results means that information on the efficacy of new drugs or other medical